RxSight (RXST) Non-Current Assets (2020 - 2026)
RxSight (RXST) posted Non-Current Assets of $24.8 million for Q1 2026, up 1.7% on a QoQ basis from $24.4 million in Q4 2025, and up 0.56% year-over-year from $24.6 million in Q1 2025.
RxSight (RXST) Non-Current Assets (2020 - 2026) Analysis & Trends
RxSight's Non-Current Assets history runs 7 years deep, the most recent figure standing at $24.8 million for Q1 2026.
- Quarterly Non-Current Assets rose 0.56% year-over-year to $24.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.9 million (up 1.61% YoY) and the FY2025 annual result came in at $24.4 million, down 1.56% from the prior year.
- Non-Current Assets was $24.8 million for Q1 2026 at RxSight, up from $24.4 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $25.1 million in Q2 2025 and bottomed at $13.9 million in Q3 2023.
- A 5-year average of $19.6 million and a median of $16.8 million in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets dropped 15.96% — and 2024, when it jumped 74.93%.
- RxSight's Non-Current Assets stood at $15.6 million in 2022, then decreased by 9.39% to $14.1 million in 2023, then soared by 74.93% to $24.7 million in 2024, then fell by 1.56% to $24.4 million in 2025, then rose by 1.7% to $24.8 million in 2026.
- Business Quant data shows RXST's Non-Current Assets at $24.8 million in Q1 2026, $24.4 million in Q4 2025, and $24.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | 24.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.77 Mn |
| Dec 31, 2025 | 24.36 Mn |
| Sep 30, 2025 | 24.66 Mn |
| Jun 30, 2025 | 25.14 Mn |
| Mar 31, 2025 | 24.63 Mn |
| Dec 31, 2024 | 24.74 Mn |
| Sep 30, 2024 | 23.70 Mn |
| Jun 30, 2024 | 24.28 Mn |
| Mar 31, 2024 | 14.61 Mn |
| Dec 31, 2023 | 14.14 Mn |
| Sep 30, 2023 | 13.90 Mn |
| Jun 30, 2023 | 14.82 Mn |
| Mar 31, 2023 | 14.87 Mn |
| Dec 31, 2022 | 15.61 Mn |
| Sep 30, 2022 | 16.54 Mn |
| Jun 30, 2022 | 16.79 Mn |
| Mar 31, 2022 | 15.92 Mn |
| Dec 31, 2021 | 16.43 Mn |
| Sep 30, 2021 | 17.40 Mn |
| Jun 30, 2021 | 19.34 Mn |